XML 45 R31.htm IDEA: XBRL DOCUMENT v3.22.1
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2022
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment

Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the three-month periods ended March 31, 2022 and 2021, were as follows (in thousands):

    

Three Months Ended

    

March 31, 

    

2022

    

2021

Net Sales

 

  

 

  

Cardiovascular

$

266,936

$

241,006

Endoscopy

 

8,479

 

7,907

Total net sales

 

275,415

 

248,913

Operating Income

 

  

 

  

Cardiovascular

 

13,126

 

12,201

Endoscopy

 

2,107

 

1,993

Total operating income

 

15,233

 

14,194

Total other expense - net

 

(1,062)

 

(1,500)

Income tax expense

 

3,626

 

1,736

Net income

$

10,545

$

10,958